散发性前庭神经鞘瘤和神经纤维瘤病 II 型中的耳蜗植入。
Cochlear Implantation in Sporadic Vestibular Schwannoma and Neurofibromatosis Type II.
机构信息
Department of ENT, Salford Royal Hospital, Stott Road, Manchester M6 8HD, UK; Department of Otolaryngology, The Richard Ramsden Centre for Hearing Implants, Peter Mount Building, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK.
Department of ENT, Salford Royal Hospital, Stott Road, Manchester M6 8HD, UK.
出版信息
Otolaryngol Clin North Am. 2023 Jun;56(3):587-598. doi: 10.1016/j.otc.2023.02.017. Epub 2023 Apr 3.
Cochlear implantation offers significantly better hearing outcomes than auditory brainstem implantation in patients with vestibular schwannoma. Neither the primary treatment modality nor the cause of the tumor (neurofibromatosis type 2 related or sporadic) seems to have a significant effect on hearing outcome with cochlear implantation. Some uncertainty remains regarding long-term hearing outcomes; however, cochlear implantation in vestibular schwannoma serves to offer patients, with a functioning cochlear nerve, the probability of open set speech discrimination with a consequent positive impact on quality of life.
耳蜗植入术为前庭神经鞘瘤患者提供了比听脑干植入术更好的听力效果。无论是主要的治疗方式还是肿瘤的病因（神经纤维瘤病 2 型相关或散发性）似乎对耳蜗植入术的听力结果没有显著影响。关于长期听力结果仍存在一些不确定性；然而，耳蜗植入术在前庭神经鞘瘤中的应用为具有功能耳蜗神经的患者提供了开放集语音辨别能力的可能性，从而对生活质量产生积极影响。
Zotero 插件